We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-2.27%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.23B
AUM Growth
-$236M
Cap. Flow
-$124M
Cap. Flow %
-3.82%
Top 10 Hldgs %
42.87%
Holding
405
New
25
Increased
177
Reduced
155
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 14.38%
2 Healthcare 6.83%
3 Financials 4.82%
4 Industrials 3.49%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFAE icon
76
Dimensional Emerging Core Equity Market ETF
DFAE
$9.29B
$9.8M 0.3%
378,657
+66,599
+21% +$1.73M
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.1T
$9.58M 0.3%
17,990
+326
+2% +$158K
NKE icon
78
Nike
NKE
$61.9B
$9.54M 0.3%
150,332
+47,487
+46% +$3.5M
SCHX icon
79
Schwab US Large- Cap ETF
SCHX
$71.8B
$9.44M 0.29%
427,552
-106,096
-20% -$2.47M
PYPL icon
80
PayPal
PYPL
$48.9B
$9.33M 0.29%
142,962
+1,589
+1% +$124K
VCR icon
81
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$9.26M 0.29%
28,452
-13,039
-31% -$4.72M
AVLC icon
82
Avantis US Large Cap Equity ETF
AVLC
$1.37B
$9.23M 0.29%
143,814
+75,802
+111% +$5.15M
XOM icon
83
ExxonMobil
XOM
$644B
$9.22M 0.29%
77,561
-66
-0.1% -$7.3K
DXCM icon
84
DexCom
DXCM
$31.5B
$9.21M 0.28%
+134,935
New +$11M
CLX icon
85
Clorox
CLX
$11.6B
$8.73M 0.27%
+59,264
New +$9.05M
BIIB icon
86
Biogen
BIIB
$30B
$8.12M 0.25%
59,334
+33,721
+132% +$4.82M
SPDW icon
87
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
$8M 0.25%
219,649
-10,888
-5% -$393K
CMCSA icon
88
Comcast
CMCSA
$85B
$7.97M 0.25%
215,880
+21,668
+11% +$782K
TMO icon
89
Thermo Fisher Scientific
TMO
$213B
$7.96M 0.25%
15,999
+1,609
+11% +$871K
EFA icon
90
iShares MSCI EAFE ETF
EFA
$78B
$7.93M 0.25%
97,006
-1,653
-2% -$133K
ABT icon
91
Abbott
ABT
$183B
$7.82M 0.24%
58,975
+851
+1% +$108K
MKC icon
92
McCormick & Company Non-Voting
MKC
$13.7B
$7.66M 0.24%
93,096
+8,559
+10% +$671K
NVO
93
Novo Nordisk
NVO
$208B
$7.43M 0.23%
106,953
+3,273
+3% +$270K
LMT icon
94
Lockheed Martin
LMT
$134B
$7.36M 0.23%
16,481
+503
+3% +$232K
LEA icon
95
Lear
LEA
$6.54B
$6.96M 0.22%
78,917
+32,019
+68% +$3.04M
MA icon
96
Mastercard
MA
$502B
$6.41M 0.2%
11,697
-29
-0.2% -$15.8K
GNRC icon
97
Generac Holdings
GNRC
$11.6B
$6.27M 0.19%
+49,468
New +$7.1M
JIRE icon
98
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.2B
$6.24M 0.19%
97,868
+49,833
+104% +$3.12M
GSK icon
99
GSK
GSK
$104B
$6.06M 0.19%
156,309
+16,434
+12% +$602K
SCHF icon
100
Schwab International Equity ETF
SCHF
$66.6B
$5.88M 0.18%
297,339
+619
+0.2% +$12.1K

Similar funds

Grimes & Company's Q1 2025 Portfolio in Review

As of Q1 2025, Grimes & Company held 405 positions worth $3.23B, down 6.8% from $3.47B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company withdrew a net $124M in Q1 2025, closing 37 positions and reducing 155 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in State Street Financial Select Sector SPDR ETF worth $18.6M.

  • Grimes & Company's largest Q1 2025 buy was State Street Financial Select Sector SPDR ETF: 372,475 shares worth $18.6M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q1 2025, an estimated $110M increase.
  • Grimes & Company's biggest Q1 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $87.4M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q1 2025, selling an estimated $13.9M.
  • Grimes & Company's ten largest holdings make up 43% of its $3.23B portfolio in Q1 2025.
  • Grimes & Company opened 25 new positions and closed 37 in Q1 2025.
  • Grimes & Company's portfolio value fell 6.8% quarter-over-quarter to $3.23B.

Based on Grimes & Company's 13F filing for Q1 2025, filed 17 Apr 2025.